Efeito antimutagênico, antigenotóxico, antiobesidade e antioxidante da Ilex paraguariensis (erva-mate)

O extrato aquoso de erva-mate, obtido a partir de folhas secas de Ilex paraguariensis, é uma bebida amplamente consumida na América do Sul. Inicialmente, nosso objetivo foi caracterizar os compostos presentes nas amostras de erva-mate disponíveis no mercado brasileiro (CH: chimarrão; T: chá mate torrado; G: chá mate torrado, comercialmente acondicionado em garrafas ou C: em copos; TS: chá mate torrado solúvel A mutagenicidade, citotoxicidade e antimutagenicidade de todas as amostras também foram avaliadas atavés do Teste de Ames na presença e na ausência de ativação metabólica. Em seguida, analisamos a amostra TS (2,5, 5,0 e 10 mg/mL) quanto a sua atividade antioxidante e antigenotóxica. Além disso, avaliamos também os efeitos da amostra TS sobre a sinalização da leptina e da insulina no hipotálamo e o estresse oxidativo hepático de ratos adultos obesos programados pela superalimentação neonatal (S). Para induzir S, o tamanho da ninhada foi reduzido a três filhotes por lactante e as ninhadas com número padrão de filhotes (dez/lactante) foram utilizadas como controle. Aos 150 dias de vida, as proles S foram subdivididas em: TS - tratados com extrato aquoso de erva-mate (1g/kg de peso corporal/dia, por gavagem) e S - recebendo água por gavagem durante 30 dias. A prole controle (C) também recebeu água nas mesmas condições do grupo S. Em nossos resultados, verificamos a presença de ácido clorogênico, cafeína e teobromina em todas as amostras analisadas. O conteúdo de compostos fenólicos nas infusões estudadas foram CH: 5,140,23; T: 4,330,01; G: 0,930,25; C: 0,800,3 e TS: 8,350,5 mg/ml. Não observamos efeito mutagênico ou citotóxico nas amostras analisadas. Um efeito antimutagênico significativo foi observado para a cepa TA97 (pré-, co- e pós-tratamento), na presença de ativação metabólica, em todas as amostras testadas. A amostra TS também apresentou um efeito antimutagênico significativo para a TA102 (pré-, co-e e pós-tratamento), na presença de ativação metabólica. Na análise exclusiva da amostra TS, observamos uma atividade antioxidante quando utilizado o ensaio de DPPH, apresentando IC50 69,3+3,1 μg/ml. Além disso, a amostra TS apresentou um efeito protetor sobre a quebra do DNA plasmidial induzida por radicais superóxido e hidroxila, de maneira dose dependente. No teste do cometa, detectamos um efeito antigenotóxico induzido pelo TS em cultura primária de células epiteliais de esôfago. Em nossos testes in vivo observamos que os animais TS não desenvolveram sobrepeso, obesidade visceral e hiperfagia. A resistência hipotalâmica à leptina não foi significativamente revertida, porém a resistência à insulina foi minimizada pelo tratamento com TS no grupo programado pela S. No fígado, TS normalizou as atividades das enzimas antioxidantes (SOD, GPx e CAT) e diminuiu os marcadores de estresse oxidativo, MDA e 4-HNE. O tratamento com TS também reduziu o conteúdo de glicogênio e triglicerídios hepáticos. Nossos resultados sugerem que a erva-mate foi capaz de proteger o DNA contra danos oxidativos, aumentou as defesas antioxidantes, melhorou a função hepática em ratos superalimentados na lactação, talvez através da modulação da sinalização hipotalâmica da insulina podendo ser, portanto, uma importante ferramenta para prevenção e tratamento de doenças relacionadas ao estresse oxidativo.

Study of histone H3 lysine 56 deacetylation in saccharomyces cerevisiae

Chez la levure Saccharomyces cerevisiae, l'acétylation de l'histone H3 sur la lysine 56 (H3K56ac) est présente sur les histones néo-synthétisées déposées derrière les fourches de réplication et est essentielle pour préserver la viabilité cellulaire en réponse au dommage à l'ADN. La désacétylation d'H3K56 sur l'ensemble du génome catalysée par Hst3 et Hst4 et a lieu en phase G2 ou M. H3K56ac est une lame à double tranchant. L'absence d'H3K56ac rend les cellules sensibles aux dommages à l'ADN. En revanche, un excès d'acétylation d'H3K56 dans un mutant hst3Δ hst4Δ a des conséquences encore plus sévères tels que la thermo-sensibilité, l'hypersensibilité aux agents génotoxiques, l'instabilité génomique ainsi qu'une courte durée de vie réplicative. Les désacétylases Hst3 et Hst4 sont étroitement régulées au cours du cycle cellulaire afin de permettre à l'H3K56ac d'exercer son rôle en réponse aux dommages à l'ADN tout en évitant les conséquences néfastes de l'hyperacétylation d'H3K56. Dans cette thèse, nous avons identifié la machinerie moléculaire responsable de la dégradation de Hst3. De plus, nous avons exploré les raisons pour lesquelles l'absence de désacétylation donne lieu aux phénotypes du mutant hst3Δ hst4Δ. Au chapitre 2, nous démontrons que la dégradation d'Hst3 peut être complétée avant l'anaphase. Ceci suggère que la désacétylation de H3K56 a lieu durant une courte fenêtre du cycle cellulaire se situant entre la complétion de la phase S et la métaphase. De plus, nous avons identifié deux sites de phosphorylation d'Hst3 par la kinase cycline-dépendante 1 (Cdk1) et démontré que ces évènements de phosphorylation conduisent à la dégradation d'Hst3 in vivo. Nous avons aussi démontré que l'ubiquityltransférase Cdc34 et l'ubiquitine ligase SCFCdc4 sont requises pour la dégradation d'Hst3. Finalement, nous avons montré que la phosphorylation d'Hst3 par la kinase mitotique Clb2-Cdk1 peut directement entraîner l'ubiquitylation d'Hst3 par SCFCdc4 in vitro. Au chapitre 3, nous avons étudié les mécanismes moléculaires sous-jacents à la sensibilité extrême du mutant hst3Δ hst4Δ aux agents qui endommagent l'ADN. Nous avons établi qu'en raison de la présence anormale d'H3K56ac devant les fourches de réplication, le mutant hst3Δ hst4Δ exhibe une forte perte de viabilité lorsqu'exposé au méthyl méthanesulfonate (MMS) durant un seul passage à travers la phase S. Nous avons aussi découvert que, malgré le fait que le point de contrôle de réponse aux dommages à l'ADN est activé normalement dans le mutant hst3Δ hst4Δ, ce mutant est incapable de compléter la réplication de l'ADN et d'inactiver le point de contrôle pour une longue période de temps après exposition transitoire au MMS. L'ensemble de nos résultats suggère que les lésions à l'ADN induites par le MMS dans le mutant hst3Δ hst4Δ causent une forte perte de viabilité parce que ce mutant est incapable de compléter la réplication de l'ADN après une exposition transitoire au MMS. Dans la deuxième section du chapitre 3, nous avons employé une approche génétique afin d'identifier de nouveaux mécanismes de suppression de deux phénotypes prononcés du mutant hst3Δ hst4Δ. Nous avons découvert que la délétion de plusieurs gènes impliqués dans la formation de frontières entre l'hétérochromatine et de l'euchromatine atténue les phénotypes du mutant hst3Δ hst4Δ sans réduire l'hyperacétylation d'H3K56. Nos résultats indiquent aussi que l'abondante acétylation de l'histone H4 sur la lysine 16 (H4K16ac) est néfaste au mutant hst3Δ hst4Δ. Ce résultat suggère un lien génétique intriguant entre l'acétylation d'H3K56 et celle d'H4K16. L'existence de ce lien était jusqu'à présent inconnu. Nous avons identifié un groupe de suppresseurs spontanés où H3K56ac est indétectable, mais la majorité de nos suppresseurs ne montrent aucune réduction flagrante d'H3K56ac ou d'H4 K16ac par rapport aux niveaux observés dans le mutant hst3Δ hst4Δ. Une étude plus approfondie de ce groupe de suppresseurs est susceptible de mener à la découverte de nouveaux mécanismes génétiques ou épigénétiques permettant d'éviter les conséquences catastrophiques de l'hyperacétylation d'H3K56 chez le mutant hst3Δ hst4Δ. En résumé, cette thèse identifie la machinerie moléculaire responsable de la dégradation d'Hst3 (une désacétylase d'H3K56) durant une fenêtre de temps situées entre la fin de la phase S et la métaphase. Nos résultats permettent aussi d'expliquer pourquoi la dégradation d'Hst3 précède le début de la phase S durant laquelle l'acétylation d'H3K56 s'accumule derrière les fourches de réplication afin d'exercer son rôle de mécanisme de défense contre le dommage à l'ADN. De plus, nous avons identifié plusieurs suppresseurs qui permettent de contourner le rôle important d'Hst3 et Hst4 en réponse au dommage à l'ADN. Plusieurs suppresseurs révèlent un lien génétique inattendu entre deux formes abondantes d'acétylation des histones chez Saccharomyces cerevisiae, soit H3K56ac et H4K16ac.

Homéostasie des histones en réponse au dommage à l’ADN et étude d’inhibiteurs de désacétylases d’importance clinique

La chromatine possède une plasticité complexe et essentielle pour répondre à différents mécanismes cellulaires fondamentaux tels la réplication, la transcription et la réparation de l’ADN. Les histones sont les constituants essentiels de la formation des nucléosomes qui assurent le bon fonctionnement cellulaire d’où l’intérêt de cette thèse d’y porter une attention particulière. Un dysfonctionnement de la chromatine est souvent associé à l’émergence du cancer. Le chapitre II de cette thèse focalise sur la répression transcriptionnelle des gènes d’histones par le complexe HIR (HIstone gene Repressor) en réponse au dommage à l'ADN chez Saccharomyces cerevisiae. Lors de dommage à l’ADN en début de phase S, les kinases du point de contrôle Mec1, Tel1 et Rad53 s’assurent de bloquer les origines tardives de réplication pour limiter le nombre de collisions potentiellement mutagéniques ou cytotoxiques entre les ADN polymérases et les lésions persistantes dans l'ADN. Lorsque la synthèse totale d’ADN est soudainement ralentie par le point de contrôle, l’accumulation d'un excès d'histones nouvellement synthétisées est néfaste pour les cellules car les histones libres se lient de manière non-spécifique aux acides nucléiques. L'un des mécanismes mis en place afin de minimiser la quantité d’histones libres consiste à réprimer la transcription des gènes d'histones lors d'une chute rapide de la synthèse d'ADN, mais les bases moléculaires de ce mécanisme étaient très mal connues. Notre étude sur la répression des gènes d’histones en réponse aux agents génotoxiques nous a permis d’identifier que les kinases du point de contrôle jouent un rôle dans la répression des gènes d’histones. Avant le début de mon projet, il était déjà connu que le complexe HIR est requis pour la répression des gènes d’histones en phase G1, G2/M et lors de dommage à l’ADN en phase S. Par contre, la régulation du complexe HIR en réponse au dommage à l'ADN n'était pas connue. Nous avons démontré par des essais de spectrométrie de masse (SM) que Rad53 régule le complexe HIR en phosphorylant directement une de ses sous-unités, Hpc2, à de multiples résidus in vivo et in vitro. La phosphorylation d’Hpc2 est essentielle pour le recrutement aux promoteurs de gènes d’histones du complexe RSC (Remodels the Structure of Chromatin) dont la présence sur les promoteurs des gènes d'histones corrèle avec leur répression. De plus, nous avons mis à jour un nouveau mécanisme de régulation du complexe HIR durant la progression normale à travers le cycle cellulaire ainsi qu'en réponse aux agents génotoxiques. En effet, durant le cycle cellulaire normal, la protéine Hpc2 est très instable durant la transition G1/S afin de permettre la transcription des gènes d’histones et la production d'un pool d'histones néo-synthétisées juste avant l'initiation de la réplication de l’ADN. Toutefois, Hpc2 n'est instable que pour une brève période de temps durant la phase S. Ces résultats suggèrent qu'Hpc2 est une protéine clef pour la régulation de l'activité du complexe HIR et la répression des gènes d’histones lors du cycle cellulaire normal ainsi qu'en réponse au dommage à l’ADN. Dans le but de poursuivre notre étude sur la régulation des histones, le chapitre III de ma thèse concerne l’analyse globale de l’acétylation des histones induite par les inhibiteurs d’histone désacétylases (HDACi) dans les cellules normales et cancéreuses. Les histones désacétylases (HDACs) sont les enzymes qui enlèvent l’acétylation sur les lysines des histones. Dans plusieurs types de cancers, les HDACs contribuent à l’oncogenèse par leur fusion aberrante avec des complexes protéiques oncogéniques. Les perturbations causées mènent souvent à un état silencieux anormal des suppresseurs de tumeurs. Les HDACs sont donc une cible de choix dans le traitement des cancers engendrés par ces protéines de fusion. Notre étude de l’effet sur l’acétylation des histones de deux inhibiteurs d'HDACs de relevance clinique, le vorinostat (SAHA) et l’entinostat (MS-275), a permis de démontrer une augmentation élevée de l’acétylation globale des histones H3 et H4, contrairement à H2A et H2B, et ce, autant chez les cellules normales que cancéreuses. Notre quantification en SM de l'acétylation des histones a révélé de façon inattendue que la stœchiométrie d'acétylation sur la lysine 56 de l’histone H3 (H3K56Ac) est de seulement 0,03% et, de manière surprenante, cette stœchiométrie n'augmente pas dans des cellules traitées avec différents HDACi. Plusieurs études de H3K56Ac chez l’humain présentes dans la littérature ont rapporté des résultats irréconciliables. Qui plus est, H3K56Ac était considéré comme un biomarqueur potentiel dans le diagnostic et pronostic de plusieurs types de cancers. C’est pourquoi nous avons porté notre attention sur la spécificité des anticorps utilisés et avons déterminé qu’une grande majorité d’anticorps utilisés dans la littérature reconnaissent d’autres sites d'acétylation de l’histone H3, notamment H3K9Ac dont la stœchiométrie d'acétylation in vivo est beaucoup plus élevée que celle d'H3K56Ac. De plus, le chapitre IV fait suite à notre étude sur l’acétylation des histones et consiste en un rapport spécial de recherche décrivant la fonction de H3K56Ac chez la levure et l’homme et comporte également une évaluation d’un anticorps supposément spécifique d'H3K56Ac en tant qu'outil diagnostic du cancer chez l’humain.

Potencial estrogênico, antimutagênico e antigenotóxico de extratos e substâncias isoladas do gênero Syngonanthus (Eriocaulaceae) e efeito inibidor na expressão de genes por xantonas de Syngonanthus nitens

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

No Relationship between the Amount of DNA Damage and the Level of hMLH1 and RASSF1A Gene Expression in Bladder Cancer Cells Treated with Cisplatin and Gemcitabine

Tumor response to antineoplastic drugs is not always predictable. This is also true for bladder carcinoma, a highly recurrent neoplasia. Currently, the combination of cisplatin and gemcitabine is well accepted as a standard protocol for treating bladder carcinoma. However, in some cases, this treatment protocol causes harmful side effects. Therefore, we investigated the roles of the genes TP53, RASSF1A (a tumor suppressor gene) and hMLH1 (a gene involved in the mismatch repair pathway) in cell susceptibility to cisplatin/gemcitabine treatment. Two bladder transitional carcinoma cell (TCC) lines, RT4 (wild-type TP53) and 5637 (mutated TP53), were used in this study. First, we evaluated whether the genotoxic potential of cisplatin/gemcitabine was dependent on TP53 status. Then, we evaluated whether the two antineoplastic drugs modulated RASSF1A and hMLH1 expression in the two cell lines. Increased DNA damage was observed in both cell lines after treatment with cisplatin or gemcitabine and with the two drugs simultaneously, as depicted by the comet assay. A lack of RASSF1A expression and hypermethylation of its promoter were observed before and after treatment in both cell lines. On the other hand, hMLH1 downregulation, unrelated to methylation status, was observed in RT4 cells after treatment with cisplatin or with cisplatin and gemcitabine simultaneously (wild-type TP53); in 5637 cells, hMLH1 was upregulated only after treatment with gemcitabine. In conclusion, the three treatment protocols were genotoxic, independent of TP53 status. However, cisplatin was the most effective, causing the highest level of DNA damage in both wild-type and mutated TP53 cells. Gemcitabine was the least genotoxic agent in both cell lines. Furthermore, no relationship was observed between the amount of DNA damage and the level of hMLH1 and RASSF1A expression. Therefore, other alternative pathways might be involved in cisplatin and gemcitabine genotoxicity in these two bladder cancer cell lines.

Participation of bcl -2 and bax in epidermal homeostasis and non-melanoma skin cancer

Non-melanoma skin cancer (NMSC) is the most frequently diagnosed form of cancer in United States. As in many other cancers, this slow growing malignancy manifests deregulated expression of apoptosis regulating proteins including bcl-2 family member proteins. To understand the role of apoptosis regulating protein in epidermal homeostasis and progression of NMSC, we investigated keratinocyte proliferation, differentiation and tumorigenesis in bcl-2 and bax null mice. The rate and the pattern of proliferation and spontaneous cell death were the same between the null and the control mice. Both bcl-2 and bax null epidermis showed decreased levels of cytokeratin 14 expression compared to the control littermates. Also, the gene knock out mice showed higher expression of cytokeratin 1 and loricrin in epidermis compared to the control mice. The apoptotic response to genotoxic agent, UV radiation (UVR), was assessed by counting sunburn cells. The bax null keratinocytes showed a resistance to apoptosis while bcl-2 null mice showed an increased susceptibility to cell death compared to the control mice. Moreover, we demonstrated an increase in tumor incidence in bax null mice compared to control littermates in the in vivo chemical carcinogenesis study. Next, we examined the tumor suppressor role of bax protein in NMSC by studying its participation in repair of UVR-mediated DNA lesions. In UVR treated primary keratinocytes from bax deficient mice, the level of CPD remaining was twice that of control cells at 48 hours. Similar results were obtained using embryonic fibroblasts from bax null and bax +/+ embryos, and also with a bax deficient prostate cancer cell line in which bax expression had been restored. However, the repair rate of 6-4 PP was unaffected by the absence of bax protein in all three of above mentioned cell types. In conclusion, bax protein may have a dual function in its role as tumor suppressor in NMSC. Bax may directly or indirectly facilitate DNA repair, or programmed cell death if DNA damage is too severe, thus, in either function, preserving genomic integrity following a genotoxic event. ^

Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway.

The WAF1/CIP1 protein has been identified as a downstream mediator of the tumor suppressor p53 in regulating cell cycle progression through a G1-phase check-point. Recent work has implicated the functional status of p53 as a critical determinant in the apoptotic response of certain cell lines to DNA damaging agents. By using human T-cell leukemia virus type I-transformed lymphoid cell lines that differ in their level and function of wild-type p53, we investigated the induction of WAF1/CIP1 and apoptosis after exposure to Adriamycin, a genotoxic agent. We found that regardless of the p53 status in these cell lines, WAF1/CIP1 RNA was rapidly induced in response to Adriamycin treatment. An elevated level of WAF1/CIP1 protein was observed as well. Additionally, we demonstrated that apoptosis was induced in all cell lines analyzed despite some having functionally inactive p53 protein. Our data suggest that a p53-independent pathway may play a role in the apoptotic response observed in some cell lines after exposure to DNA damaging agents.

Black bean (Phaseolus vulgaris L.) as a protective agent against DNA damage in mice

This study was designed to evaluate the toxicogenetic or protective effect of cooked and dehydrated black beans (Phaseolus vulgaris L.) in bone marrow and peripheral blood cells of exposed mice. The frequency of micronuclei detected using the bone marrow erythrocyte micronucleus test and level of DNA lesions detected by the comet assay were chosen as end-points reflecting mutagenic and genotoxic damage, respectively. Initially, Swiss male mice were fed with a 20% black bean diet in order to detect mutagenic and genotoxic activity. However, no increase in the frequency of bone marrow micronucleated polychromatic erythrocytes (MN PCEs) or DNA lesion in leukocytes was observed. In contrast, received diets containing 1, 10 or 20% of black beans, a clear, but not dose-dependent reduction in the frequency of MN PCEs were observed in animals simultaneously treated with cyclophosphamide, an indirect acting mutagen. Similar results were observed in leukocytes by the comet assay. Commercial anthocyanin was also tested in an attempt to identify the bean components responsible for this protective effect. However, instead of being protective, the flavonoid, at the highest dose administered (50 mg/kg bw), induced primary DNA lesion, as detected by the comet assay. These data indicate the importance of food components in preventing genetic damage induced by chemical mutagens, and also reinforce the role of toxicogenetic techniques in protecting human health. (C) 2003 Elsevier Ltd. All rights reserved.

Investigation of cytotoxic, apoptosis-inducing, genotoxic and protective effects of the flavonoid rutin in HTC hepatic cells

Rutin is a flavonoid with antioxidant, vasodilatory, anti-inflammatory and immune-stimulating activities. To study the toxicity of rutin and its protective effect, this work investigated the cytotoxic, apoptosis-inducing, genotoxic and protective effects of rutin in HTC cells. In the MTT assay, the highest concentration tested (810 mu M) showed cytotoxicity after 72 h of treatment, where cell viability and cell proliferation was diminished. None of the concentrations of rutin tested induced apoptosis after 24 h treatment. The highest concentration of rutin after 24 h treatment induced DNA damage, shown in the comet assay, but did have a genotoxic effect in the micronucleus test. Rutin was tested against the pro-carcinogenic agent benzo(a)pyrene, at concentrations of 90, 270 and 810 mu M, and was found to reduce induced DNA damage significantly. This protective effect of rutin against a pro-carcinogen, suggests an important biological activity for this compound, which can contribute to human health through the diet. (C) 2010 Elsevier GmbH. All rights reserved.

Anti-genotoxic effect of aqueous extracts of sun mushroom (Agaricus blazei Murill lineage 99/26) in mammalian cells in vitro

The sun mushroom is the popular name for the Agaricus blazei Murill fungus, a mushroom native to south-eastern Brazil, which has been frequently used in popular medicine mainly in the form of tea to treat various ailments (stress, diabetes, etc.). In the present study, the genotoxic and/or anti-genotoxic effects ofA. blazei on mammalian cells in culture was assessed by checking the increase or reduction of micronucleus (MN) frequency and comets. The sun mushroom (lineage 99/26) was used as aqueous extracts prepared (2.5%) at three different temperatures (60, 25 and 4°C). The in vitro micronucleus (MN) test in binucleated cells and comet assay were used in V79 cells cultivated in HAM-F10+DMEM medium (1:1), supplemented with 10% of fetal bovine serum. The experiments were divided into four treatment types: 1. Negative control; 2. Positive control with MMS; 3. Treatments with the three forms of extracts (60, 25 and 4°C); and 4. Treatments with the extracts in different associations (simultaneous, pre-treatment, post-treatment and simultaneous after pre-incubation for 1 h) with MMS. None of the A. blazei extracts show genotoxic activity. In the comet assay no protecting effect was found. The results obtained in the MN test showed that the three forms of extracts used had protective activity, suggesting that the compound or active ingredients of A. blazei are always present in these extracts. The greater protective efficiency of the simultaneous treatment and simultaneous treatment with pre-incubation mixture with MMS suggests that the extracts have an antimutagenic action of the desmutagenic type. © 2002 Elsevier Science Ltd. All rights reserved.

In vitro cytotoxic and non-genotoxic effects of gutta-percha solvents on mouse lymphoma cells by single cell gel (comet) assay

Chloroform and eucalyptol are widely used in clinical dentistry as gutta-percha solvents. However, these compounds may represent a hazard to human health, especially by causing injury to genetic apparatus and/or inducing cellular death. In this study, the genotoxic and cytotoxic potentials associated with exposure to chloroform and eucalyptol were assessed on mouse lymphoma cells in vitro by the single cell gel (comet) assay and trypan blue exclusion test, respectively. Both gutta-percha solvents proved to be cytotoxic at the same levels in concentrations of 2.5, 5 and 10 μL/mL (p<0.05). On the other hand, neither of the solvents induced DNA breakage. Taken together, these results suggest that although both tested compounds (chloroform and eucalyptol) are strong cytotoxicants, it seems that they are not likely to increase the level of DNA damage on mammalian cells.

Absence of genotoxic effects of the coumarin derivative 4-methylesculetin in vivo and its potential chemoprevention against doxorubicin-induced DNA damage

4-Methylesculetin (4-ME) is a synthetic derivative of coumarin that displays a potent reactive oxygen species (ROS) scavenger and metal chelating agent and therefore has been produced to help reduce the risk of human disease. The main objective of this study was to investigate the in vivo genotoxicity of 4-ME and initially to verify its potential antigenotoxicity on doxorubicin (DXR)-induced DNA damage. Different doses of 4-ME (500, 1000 and 2000mgkg -1 body weight) were administered by gavage only or with a simultaneous intraperitoneal (i.p.) injection of DXR (80mgkg -1). The following endpoints were analyzed: DNA damage in peripheral blood, liver, bone marrow, brain and testicle cells according to an alkaline (pH>13) comet assay and micronucleus induction in bone marrow cells. Cytotoxicity was assessed by scoring polychromatic (PCE) and normochromatic (NCE) erythrocytes (PCE/NCE ratio). No differences were observed between the negative control and the groups treated with a 4-ME dose for any of the endpoints analyzed, indicating that it lacks genotoxic and cytotoxic effects. Moreover, 4-ME demonstrated protective effects against DXR-induced DNA damage at all tested doses and in all analyzed cell types, which ranged from 34.1% to 93.3% in the comet assay and 54.4% to 65.9% in the micronucleus test.

Dragon's blood Croton palanostigma induces genotoxic effects in mice

Ethnopharmacological relevance Dragon's blood is a dark-red sap produced by species from the genus Croton (Euphorbiaceae), which has been used as a famous traditional medicine since ancient times in many countries, with scarce data about its safe use in humans. In this research, we studied genotoxicity and clastogenicity of Croton palanostigma sap using the comet assay and micronucleus test in cells of mice submitted to acute treatment. Material and methods HPLC analysis was performed to identify the main components of the sap. The sap was administered by oral gavage at doses of 300 mg/kg, 1000 mg/kg and 2000 mg/kg. For the analysis, the comet assay was performed on the leukocytes and liver cells collected 24 h after treatment, and the micronucleus test (MN) on bone marrow cells. Cytotoxicity was assessed by scoring 200 consecutive polychromatic (PCE) and normochromatic (NCE) erythrocytes (PCE/NCE ratio). Results and conclusion The alkaloid taspine was the main compound indentified in the crude sap of Croton palanostigma. The results of the genotoxicity assessment show that all sap doses tested produced genotoxic effects in leukocytes and liver cells and also produced clastogenic/aneugenic effects in bone marrow cells of mice at the two higher doses tested. The PCE/NCE ratio indicated no cytotoxicity. The data obtained suggest caution in the use of Croton palanostigma sap by humans considering its risk of carcinogenesis. © 2013 Elsevier B.V. All rights reserved.

Evaluation of estrogenic, antiestrogenic and genotoxic activity of nemorosone, the major compound found in brown Cuban propolis

Background: Brown propolis is the major type of propolis found in Cuba; its principal component is nemorosone, the major constituent of Clusia rosea floral resins. Nemorosone has received increasing attention due to its strong in vitro anti-cancer action. The citotoxicity of nemorosone in several human cancer cell lines has been reported and correlated to the direct action it has on the estrogen receptor (ER). Breast cancer can be treated with agents that target estrogen-mediated signaling, such as antiestrogens. Phytoestrogen can mimic or modulate the actions of endogenous estrogens and the treatment of breast cancer with phytoestrogens may be a valid strategy, since they have shown anti-cancer activity.Methods: The aim of the present investigation was to assess the capacity of nemorosone to interact with ERs, by Recombinant Yeast Assay (RYA) and E-screen assays, and to determine by comet assay, if the compound causes DNA-damaging in tumoral and non-tumoral breast cells.Results: Nemorosone did not present estrogenic activity, however, it inhibited the 17-β-estradiol (E2) action when either of both methods was used, showing their antiestrogenicity. The DNA damage induced by the benzophenone in cancer and normal breast cells presented negative results.Conclusion: These findings suggest that nemorosone may have therapeutic application in the treatment of breast cancer. © 2013 Camargo et al.; licensee BioMed Central Ltd.

Genotoxic effect of photodynamic therapy mediated by curcumin on Candida albicans

Photodynamic therapy (PDT) is a promising method for localized and specific inactivation of fungi and bacteria. A nontoxic light-sensitive compound is taken up by cells, which are then exposed selectively to light, which activates toxicity of the compound. We investigated the potential of sublethal PDT using light-sensitive curcumin (CUR) in combination with blue (455 nm) light to promote reactive oxygen species (ROS) formation in the form of singlet oxygen and DNA damage of Candida albicans. Surprisingly, CUR-mediated PDT but also light alone caused significantly longer comet tails, an indication of DNA damage of C. albicans when compared with the negative control. The intracellular ROS production was also significantly higher for the group treated only with light. However, PDT compared to blue light alone significantly slowed DNA repair. Comet tails decreased during 30 min visualized as a 90% reduction in length in the absence of light for cells treated with light alone, while comet tails of cells treated with PDT only diminished in size about 45%. These results indicate that complex mechanisms may result in PDT in a way that should be considered when choosing the photosensitive compound and other aspects of the treatment design.